BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37632543)

  • 1. Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence.
    Wang C; Li K; Huang Z; Yuan Y; He W; Zheng Y; Zou R; Li B; Yuan Y; Qiu J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15113-15125. PubMed ID: 37632543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal treatment strategy for recurrent hepatocellular carcinoma based on recurrence time and tumor size: A propensity score matching study.
    Wan W; Zhang H; Ji T; Zhang L; Luo K; Xiong D
    Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102157. PubMed ID: 37321321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat hepatic resection combined with intraoperative radiofrequency ablation versus repeat hepatic resection alone for recurrent and multiple hepatocellular carcinoma patients meeting the Barcelona Clinic Liver Cancer stage A: A propensity score-matched analysis.
    Huang Y; Xu L; Huang M; Jiang L; Xu M
    Cancer Med; 2023 Apr; 12(8):9213-9227. PubMed ID: 36722129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat hepatectomy versus microwave ablation for solitary and small (≤3 cm) recurrent hepatocellular carcinoma with early or late recurrence: A propensity score matched study.
    Wang WQ; Lv X; Li J; Li J; Wang JL; Yuan T; Liu JJ; Zhu RH; Huang ZY; Zhang EL
    Eur J Surg Oncol; 2023 May; 49(5):1001-1008. PubMed ID: 36585301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation versus repeat hepatectomy in the treatment of recurrent hepatocellular carcinoma in subcapsular location: a retrospective cohort study.
    Wei F; Huang Q; Zhou Y; Luo L; Zeng Y
    World J Surg Oncol; 2021 Jun; 19(1):175. PubMed ID: 34127007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.
    Xia Y; Li J; Liu G; Wang K; Qian G; Lu Z; Yang T; Yan Z; Lei Z; Si A; Wan X; Zhang H; Gao C; Cheng Z; Pawlik TM; Wang H; Lau WY; Wu M; Shen F
    JAMA Oncol; 2020 Feb; 6(2):255-263. PubMed ID: 31774468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
    Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
    Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat hepatectomy versus radiofrequency ablation in management of recurrent hepatocellular carcinoma: an average treatment effect analysis.
    Chua DW; Koh YX; Syn NL; Chuan TY; Yao TJ; Lee SY; Goh BKP; Cheow PC; Chung AY; Chan CY
    Ann Surg Oncol; 2021 Nov; 28(12):7731-7740. PubMed ID: 33969464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term outcomes of percutaneous microwave ablation versus repeat hepatectomy for treatment of late recurrent small hepatocellular carcinoma: a retrospective study].
    Zhang T; Li K; Luo H; Zhang W; Zhang L; Gao M
    Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(33):2570-2. PubMed ID: 25511485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical resection versus radiofrequency ablation for early recurrent hepatocellular carcinoma.
    Shi T; Xu C; Feng Y; Wei Y; Lv H; Zhu Q
    Eur J Gastroenterol Hepatol; 2022 Aug; 34(8):844-851. PubMed ID: 35694799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Yeow M; Zhao JJ; Fong KY; Wong J; Tan AYH; Kam JH; Nikfarjam M; Goh BKP; Kabir T
    World J Surg; 2022 Nov; 46(11):2778-2787. PubMed ID: 35989371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis.
    Xing H; Sun LY; Yan WT; Quan B; Liang L; Li C; Zhou YH; Wang H; Zhong JH; Gu WM; Chen TH; Wang MD; Wu H; Pawlik TM; Lau WY; Wu MC; Shen F; Yang T
    Surgery; 2021 Apr; 169(4):911-920. PubMed ID: 31879090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
    Chen SL; Xiao H; Xie ZL; Shen JX; Chen ZB; Wang YQ; Li B; Peng ZW; Kuang M; Lai JM; Peng S
    Eur Radiol; 2020 Jun; 30(6):3473-3485. PubMed ID: 32048035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis.
    Zhou Q; Wang X; Li R; Wang C; Wang J; Xie X; Li Y; Li S; Mao X; Liang P
    J Gastroenterol; 2022 Sep; 57(9):684-694. PubMed ID: 35816221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Percutaneous radiofrequency ablation combined with other minimally invasive treatments for recurrent hepatocellular carcinoma after hepatectomy].
    Xu L; Li P; Chen MS; Pang XH; Gao HJ; Peng ZW; Liang HH; Zhang YJ; Li JQ
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1617-20. PubMed ID: 19094753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival analysis of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma conforming to the Milan criteria: primary versus recurrent HCC.
    Zhang J; Guo G; Li T; Guo C; Han Y; Zhou X
    Int J Hyperthermia; 2024; 41(1):2318829. PubMed ID: 38467417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.